Koninklijke Philips | PHG - Cost Of Sales


Koninklijke Philips reported EUR2.14B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Abbott USD 5.3B 380M Mar/2026
Baxter International USD 1.81B 587M Mar/2026
Becton, Dickinson and Co. USD 2.56B 281M Mar/2026
Boston Scientific USD 1.83B 8M Mar/2026
Danaher USD 2.36B 512M Mar/2026
Demant DKK 2.89B 188M Dec/2025
Dexcom USD 441.6M 25.3M Mar/2026
Edwards Lifesciences USD 362.6M 19.6M Mar/2026
Fresenius EUR 4.45B 262M Dec/2025
General Electric Aerospace USD 8.15B 764M Mar/2026
Getinge SEK 6.02B 1.7B Dec/2024
Globus Medical USD 263.59M 26.88M Mar/2026
GN Store Nord DKK 1.16B 1.08B Mar/2026
Hitachi JPY 2.14T 235B Mar/2026
Idexx Laboratories USD 418.08M 14.38M Mar/2026
Insulet USD 232.7M 17.5M Mar/2026
Integra LifeSciences USD 178.71M 14.73M Mar/2026
Intuitive Surgical USD 940.3M 21.6M Mar/2026
J&J USD 8.07B 103M Mar/2026
Koninklijke Philips EUR 2.14B 1.13B Mar/2026
Medtronic USD 3.8B 195M Mar/2026
Philips EUR 2.14B 669M Mar/2026
ResMed USD 551.67M 4.17M Mar/2026
Smith & Nephew USD 870M 17M Dec/2025
Steris USD 891.3M 50.6M Mar/2026
Stryker USD 2.36B 325M Mar/2026
Teleflex USD 240.84M 20.7M Mar/2026
Terumo JPY 151.3B 7.86B Mar/2026
Zimmer Biomet Holdings USD 738.3M 231.8M Mar/2026